STOCK TITAN

Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
management

Rubicon Organics (ROMJF) has appointed Glen Ibbott, former CFO of Aurora Cannabis, as its Interim Chief Financial Officer, effective May 15, 2025. Ibbott replaces Janis Risbin, who will transition to an advisory role. With over 25 years of leadership experience in publicly-traded companies, Ibbott is known for his significant role at Aurora Cannabis (2017-2024), where he drove rapid growth and achieved positive EBITDA. His experience includes senior finance roles at healthcare companies and a crucial role in QLT Inc.'s $500 million merger with Aegerion Pharmaceuticals.

Ibbott, who holds dual CPA designations and MBAs from Cornell and Queen's University, joins Rubicon as the company plans to scale new capacity and explore international markets. The company has initiated a search for a permanent CFO, considering both internal and external candidates.

Rubicon Organics (ROMJF) ha nominato Glen Ibbott, ex CFO di Aurora Cannabis, come Direttore Finanziario ad interim, con effetto dal 15 maggio 2025. Ibbott sostituisce Janis Risbin, che assumerà un ruolo di consulenza. Con oltre 25 anni di esperienza dirigenziale in società quotate, Ibbott è noto per il suo ruolo chiave in Aurora Cannabis (2017-2024), dove ha guidato una rapida crescita e raggiunto un EBITDA positivo. La sua esperienza comprende ruoli finanziari senior in aziende del settore sanitario e un ruolo fondamentale nella fusione da 500 milioni di dollari tra QLT Inc. e Aegerion Pharmaceuticals.

Ibbott, che possiede doppia certificazione CPA e MBA conseguiti presso Cornell e Queen's University, entra in Rubicon mentre l'azienda pianifica di espandere la capacità produttiva e di esplorare mercati internazionali. La società ha avviato la ricerca di un CFO permanente, valutando candidati sia interni che esterni.

Rubicon Organics (ROMJF) ha nombrado a Glen Ibbott, ex CFO de Aurora Cannabis, como Director Financiero interino, con efecto a partir del 15 de mayo de 2025. Ibbott reemplaza a Janis Risbin, quien pasará a un rol asesor. Con más de 25 años de experiencia en liderazgo en empresas cotizadas, Ibbott es reconocido por su papel destacado en Aurora Cannabis (2017-2024), donde impulsó un crecimiento rápido y logró un EBITDA positivo. Su experiencia incluye cargos financieros senior en compañías de salud y un papel clave en la fusión de 500 millones de dólares entre QLT Inc. y Aegerion Pharmaceuticals.

Ibbott, quien posee doble certificación CPA y MBAs de Cornell y Queen's University, se une a Rubicon mientras la empresa planea ampliar su capacidad y explorar mercados internacionales. La compañía ha iniciado la búsqueda de un CFO permanente, considerando candidatos tanto internos como externos.

Rubicon Organics (ROMJF)는 2025년 5월 15일부터 전 Aurora Cannabis CFO인 Glen Ibbott를 임시 최고재무책임자(CFO)로 임명했습니다. Ibbott는 자문 역할로 전환하는 Janis Risbin을 대신합니다. 상장 기업에서 25년 이상의 리더십 경험을 가진 Ibbott는 2017년부터 2024년까지 Aurora Cannabis에서 빠른 성장과 긍정적인 EBITDA 달성에 중요한 역할을 한 것으로 알려져 있습니다. 또한 의료 분야의 고위 재무직과 QLT Inc.의 5억 달러 규모 Aegerion Pharmaceuticals와의 합병에서 핵심적인 역할을 수행했습니다.

코넬 대학교와 퀸스 대학교에서 MBA를 취득하고 CPA 자격증을 두 개 보유한 Ibbott는 Rubicon이 생산 능력을 확장하고 국제 시장을 탐색하려는 계획을 추진하는 가운데 합류했습니다. 회사는 내부 및 외부 후보를 고려하여 영구 CFO 선임을 위한 검색을 시작했습니다.

Rubicon Organics (ROMJF) a nommé Glen Ibbott, ancien directeur financier d'Aurora Cannabis, en tant que directeur financier par intérim, à compter du 15 mai 2025. Ibbott succède à Janis Risbin, qui passera à un rôle de conseiller. Fort de plus de 25 ans d'expérience en leadership dans des entreprises cotées en bourse, Ibbott est reconnu pour son rôle majeur chez Aurora Cannabis (2017-2024), où il a stimulé une croissance rapide et atteint un EBITDA positif. Son expérience inclut des postes financiers seniors dans des entreprises de santé ainsi qu'un rôle clé dans la fusion de 500 millions de dollars entre QLT Inc. et Aegerion Pharmaceuticals.

Détenteur de doubles certifications CPA et de MBA de Cornell et de Queen's University, Ibbott rejoint Rubicon alors que la société prévoit d'accroître ses capacités et d'explorer les marchés internationaux. L'entreprise a lancé une recherche pour un CFO permanent, en considérant des candidats internes et externes.

Rubicon Organics (ROMJF) hat Glen Ibbott, den ehemaligen CFO von Aurora Cannabis, mit Wirkung zum 15. Mai 2025 als Interims-Chief Financial Officer ernannt. Ibbott ersetzt Janis Risbin, die in eine beratende Funktion wechseln wird. Mit über 25 Jahren Führungserfahrung in börsennotierten Unternehmen ist Ibbott bekannt für seine bedeutende Rolle bei Aurora Cannabis (2017-2024), wo er ein schnelles Wachstum vorantrieb und ein positives EBITDA erzielte. Seine Erfahrung umfasst leitende Finanzpositionen in Gesundheitsunternehmen sowie eine entscheidende Rolle bei der 500-Millionen-Dollar-Fusion von QLT Inc. mit Aegerion Pharmaceuticals.

Ibbott, der über doppelte CPA-Zertifizierungen und MBAs von der Cornell University und der Queen's University verfügt, kommt zu Rubicon, während das Unternehmen plant, neue Kapazitäten auszubauen und internationale Märkte zu erschließen. Das Unternehmen hat die Suche nach einem dauerhaften CFO eingeleitet und berücksichtigt dabei sowohl interne als auch externe Kandidaten.

Positive
  • Appointment of experienced cannabis industry veteran Glen Ibbott as interim CFO, bringing expertise from Aurora Cannabis
  • Company reports having more demand than supply for its premium cannabis products
  • New production capacity expansion planned for this year
  • International expansion opportunities with certifications already in place
Negative
  • Loss of long-term CFO Janis Risbin who served since 2019
  • Temporary nature of the CFO position creates uncertainty until permanent replacement is found

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX: ACB, Nasdaq: ACB) as its Interim Chief Financial Officer.

Janis Risbin, current CFO, will be stepping away from her full-time role effective today. She will remain in an advisory role over the next few months to ensure a smooth transition of responsibilities to Mr. Ibbott.

“Glen’s leadership at Aurora Cannabis helped to build one of the largest cannabis companies in Canada. His expertise comes at an important time for Rubicon Organics as we scale new capacity and explore new markets for our industry leading premium cannabis brands. His strategic insight and financial leadership will be instrumental as we navigate our next phase of growth and innovation,” said Margaret Brodie, CEO.

Ms. Brodie continued, "On behalf of our Board of Directors, and the entire Rubicon Organics team, I would like to offer our sincere thanks and appreciation to Janis. Since 2019, Janis has dedicated immeasurable time and energy to Rubicon; and we have been fortunate to have her expertise over the years as we navigated this emerging industry. We wish her all the best for her future endeavours."

Mr. Ibbott commented, “It’s an exciting time to join Rubicon Organics. The leading premium cannabis products with more demand than supply, new capacity coming on this year, and certifications in place for international expansion. I believe Rubicon has been a hidden gem in the financial markets that is now ready to shine with the best of the industry.”

Glen Ibbott is a seasoned financial executive with over 25 years of leadership experience in publicly-traded life sciences and cannabis companies. He is best known in the industry for his tenure as CFO at Aurora Cannabis from 2017 to 2024, where he played a pivotal role in the company’s rapid growth, international expansion, and delivery of recurring EBITDA and cash flow. Prior to Aurora, Mr. Ibbott held senior finance roles at several prominent healthcare and pharmaceutical companies, including QLT Inc., where he was instrumental in its $500 million merger with Aegerion Pharmaceuticals. He began his career at KPMG and holds dual CPA designations in Canada and the U.S., as well as MBAs from Cornell University and Queen’s University. His strategic acumen and deep industry knowledge make him a valuable asset in guiding companies through complex financial landscapes.

We will be initiating a comprehensive search process to identify a permanent CFO. This process will include both internal and external candidates and will be guided by our commitment to finding a leader with deep financial expertise, a strong understanding of the cannabis industry, and a vision aligned with our long-term strategic goals.

ABOUT RUBICON ORGANICS

Rubicon Organics Inc. is a global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare™ Organic, its premium brand 1964 Supply Co™, and its cannabis wellness brand Wildflower™ in addition to the Company’s mainstream brand Homestead Cannabis Supply™.

The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada.

CONTACT INFORMATION

Rubicon Organics Inc.
Margaret Brodie, CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com
505-744 West Hastings Street
Vancouver, BC V6C 1A5

The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ goal of achieving industry leading profitability are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based on certain assumptions that management considers reasonable under the circumstances. These statements are based on current expectations, estimates, and projections about the Company’s business and the industry in which it operates. Risks and uncertainties associated with the forward-looking information in this press release include, among others, risks related to the recently completed Offering, including that the Company does not use the proceeds from the Offering as anticipated, risks related to regulatory approvals, changes in market conditions, competition, supply chain disruptions, the Company's ability to maintain certification standards, and the successful implementation of its business strategy. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.


FAQ

Who is the new interim CFO of Rubicon Organics (ROMJF)?

Glen Ibbott, former CFO of Aurora Cannabis (2017-2024), has been appointed as interim CFO of Rubicon Organics effective May 15, 2025.

What is Glen Ibbott's experience in the cannabis industry?

Glen Ibbott served as CFO at Aurora Cannabis from 2017 to 2024, where he led the company's rapid growth, international expansion, and achievement of positive EBITDA and cash flow.

Why did Rubicon Organics (ROMJF) change its CFO?

Janis Risbin, the current CFO since 2019, is stepping away from her full-time role. She will remain in an advisory role for several months to ensure a smooth transition while the company searches for a permanent CFO.

What are Rubicon Organics' (ROMJF) current business opportunities?

The company reports having more demand than supply for its premium cannabis products, new production capacity coming online this year, and certifications in place for international expansion.

What is Glen Ibbott's educational and professional background?

Glen Ibbott holds dual CPA designations in Canada and the U.S., MBAs from Cornell and Queen's University, and has over 25 years of leadership experience in publicly-traded life sciences and cannabis companies.
Rubicon Organics

OTC:ROMJF

ROMJF Rankings

ROMJF Latest News

ROMJF Stock Data

18.81M
26.33M
43.66%
3.69%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver